NO20065321L - Fremgangsmate for fremstilling av clopidogrelhydrogensulfat polymorf for I - Google Patents

Fremgangsmate for fremstilling av clopidogrelhydrogensulfat polymorf for I

Info

Publication number
NO20065321L
NO20065321L NO20065321A NO20065321A NO20065321L NO 20065321 L NO20065321 L NO 20065321L NO 20065321 A NO20065321 A NO 20065321A NO 20065321 A NO20065321 A NO 20065321A NO 20065321 L NO20065321 L NO 20065321L
Authority
NO
Norway
Prior art keywords
preparation
hydrogen sulfate
clopidogrel hydrogen
sulfate polymorph
polymorph
Prior art date
Application number
NO20065321A
Other languages
English (en)
Other versions
NO339878B1 (no
Inventor
Haifang Mao
Hongguang Qian
Chen Chen
Original Assignee
Krka Tovarna Zdravil Dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CN 200410009028 external-priority patent/CN1690060A/zh
Priority claimed from SI200400122A external-priority patent/SI21749A/sl
Application filed by Krka Tovarna Zdravil Dd filed Critical Krka Tovarna Zdravil Dd
Publication of NO20065321L publication Critical patent/NO20065321L/no
Publication of NO339878B1 publication Critical patent/NO339878B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Det er beskrevet fremgangsmåter for fremstilling av klopridogrelhydrogensulfat av polymorf form I, disse omfatter anvendelse av spesifikke løsningsmidler og fremgangsmåtetrekk for å unngå dannelsen av uønskede biprodukter.
NO20065321A 2004-04-19 2006-11-20 Fremgangsmåte for fremstilling av clopidogrelhydrogensulfat polymorf form I NO339878B1 (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN 200410009028 CN1690060A (zh) 2004-04-19 2004-04-19 一种制备i型硫酸氯吡格雷的方法
SI200400122A SI21749A (sl) 2004-04-21 2004-04-21 Postopek za pripravo polimorfne oblike I klopidogrel hidrogen sulfata
PCT/EP2005/004160 WO2005100364A1 (en) 2004-04-19 2005-04-19 Processes for the preparation of clopidogrel hydrogen sulfate polymorphic form i

Publications (2)

Publication Number Publication Date
NO20065321L true NO20065321L (no) 2007-01-09
NO339878B1 NO339878B1 (no) 2017-02-13

Family

ID=34965241

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20065321A NO339878B1 (no) 2004-04-19 2006-11-20 Fremgangsmåte for fremstilling av clopidogrelhydrogensulfat polymorf form I

Country Status (10)

Country Link
US (1) US7999106B2 (no)
EP (1) EP1740593B1 (no)
EA (1) EA010198B1 (no)
ES (1) ES2577303T3 (no)
HR (1) HRP20160757T1 (no)
HU (1) HUE029459T2 (no)
NO (1) NO339878B1 (no)
PL (1) PL1740593T3 (no)
SI (1) SI1740593T1 (no)
WO (1) WO2005100364A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7772398B2 (en) * 2005-03-11 2010-08-10 Dr. Reddy's Laboratories, Inc. Process for making crystalline form I of clopidogrel hydrogen sulphate
US20090093635A1 (en) * 2006-03-09 2009-04-09 Sandor Garadnay PROCESS FOR MAKING POLYMORPH FROM I OF (S) - (+) -METHYL-ALPHA- (2-CHLOROPHENYL) -6, 7-DYHIDRO-THIENO- [3, 2-c] PYRIDINE-5 (4H) -ACETATE HYDROGEN SULFATE
KR20080055860A (ko) * 2006-08-03 2008-06-19 테바 파마슈티컬 인더스트리즈 리미티드 클로피도그렐 바이설페이트의 제조 방법
WO2008032995A1 (en) * 2006-09-15 2008-03-20 Boryung Pharmaceutical Co., Ltd Clopidogrel(+)-camphorsulfonate salt, method of preparing the same and a pharmaceutical composition comprising the same
SI22383A (sl) * 2006-09-22 2008-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze klopidogrela in nove oblike njegovih farmacevtsko sprejemljivih soli
WO2008068569A2 (en) * 2006-12-01 2008-06-12 Wockhardt Research Centre Processes for the preparation of clopidogrel hydrochloride
EP2114957A4 (en) * 2007-01-29 2011-06-08 Ipca Lab Ltd PROCESS FOR PREPARING CRYSTALLINE CLOPIDOGRAPHYDROGENSULFATE OF FORM I
PL382055A1 (pl) * 2007-03-23 2008-09-29 Koźluk Tomasz Nobilus Ent Sposób wytwarzania formy krystalicznej 1 wodorosiarczanu klopidogrelu
EP2107061A1 (en) * 2008-04-02 2009-10-07 Krka Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically enriched clopidogrel
WO2011042804A2 (en) 2009-10-08 2011-04-14 Jubliant Life Sciences Limited An improved process for the preparation of clopidogrel hydrogen sulfate form i
WO2011051976A2 (en) * 2009-10-30 2011-05-05 Matrix Laboratories Ltd An improved process for the preparation of clopidogrel bisulfate form i
WO2011125069A1 (en) * 2010-03-22 2011-10-13 Rpg Life Sciences Limited A process for preparation of crystalline form i of clopidogrel bisulfate
CN103360406A (zh) * 2012-03-26 2013-10-23 黑龙江福和华星制药集团股份有限公司 一种制备i型硫酸氢氯吡格雷的方法
CN102924474B (zh) * 2012-11-08 2015-04-01 浙江海翔药业股份有限公司 一种氯吡格雷硫酸氢盐晶型ⅰ的制备方法
SI3060551T1 (sl) 2013-10-22 2019-11-29 Chiesi Farm Spa Postopek za pripravo inhibitorja PDE4
MX383691B (es) 2015-03-06 2025-03-14 Beyondspring Pharmaceuticals Inc Método de tratamiento de cáncer asociado con una mutación de ras.
KR101710922B1 (ko) 2015-06-03 2017-02-28 경동제약 주식회사 클로피도그렐 황산염 결정형 i형의 제조방법
SG10201911417PA (en) 2015-06-17 2020-01-30 Otsuka America Pharmaceutical Inc Crystalline compounds
US10155748B2 (en) 2015-07-13 2018-12-18 Beyondspring Pharmaceuticals, Inc. Plinabulin compositions
WO2017139231A1 (en) 2016-02-08 2017-08-17 Beyondspring Pharmaceuticals, Inc. Compositions containing tucaresol or its analogs
RU2760348C2 (ru) 2016-06-06 2021-11-24 Бейондспринг Фармасьютикалс, Инк. Способ уменьшения нейтропении
JP2020503363A (ja) 2017-01-06 2020-01-30 ビヨンドスプリング ファーマシューティカルズ，インコーポレイテッド チューブリン結合化合物およびその治療的使用
BR112019015974A2 (pt) 2017-02-01 2020-03-31 Beyondspring Pharmaceuticals, Inc. Método para reduzir neutropenia
WO2018149608A1 (en) 2017-02-16 2018-08-23 Sandoz Ag Crystalline forms of cabotegravir sodium
KR20200112881A (ko) 2018-01-24 2020-10-05 비욘드스프링 파마수티컬스, 인코포레이티드. 플리나불린의 투여를 통해 혈소판감소증을 감소시키는 조성물 및 방법
TW202028208A (zh) 2018-10-09 2020-08-01 瑞士商諾華公司 N-(4-氟-3-(6-(3-甲基吡啶-2-基)-[1,2,4]三唑并[1,5-a]嘧啶-2-基)苯基)-2,4-二甲基㗁唑-5-甲醯胺固體形式
CA3215047A1 (en) 2021-04-09 2022-10-13 Lan Huang Therapeutic compositions and methods for treating tumors

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2779726B1 (fr) 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
WO2002018357A1 (en) 2000-08-29 2002-03-07 Rpg Life Sciences Limited A ONE-POT PROCESS FOR THE PREPARATION OF PHARMACEUTICALLY ACCEPTABLE ACID ADDITION SALTS OF 4, 5, 6, 7 - TETRAHYDROTHIENO (3,2-c) PYRIDINE DERIVATIVES HAVING ANTITHROMBOTIC ACTIVITY
GB0125708D0 (en) 2001-10-26 2001-12-19 Generics Uk Ltd Novel compounds and processes
JP2005514387A (ja) 2001-12-18 2005-05-19 テバ ファーマシューティカル インダストリーズ リミティド クロピドグレル硫酸水素塩の多型体
US7309710B2 (en) 2002-08-27 2007-12-18 Astellas Pharma Inc. Crystals
CZ297472B6 (cs) 2002-08-27 2006-12-13 Zentiva, A.S. Zpusob výroby clopidogrelu hydrogensulfátu krystalické formy I
AU2003285841A1 (en) 2002-11-28 2004-06-18 Anpharm Przedsiebiorstwo Farmaceutyczne S.A. A process for the preparation of crystalline form 1 or clopidogrel hydrogen sulfate
AU2003238664A1 (en) * 2003-03-12 2004-09-30 Cadila Healthcare Limited Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate
US20070142637A1 (en) * 2003-07-02 2007-06-21 Egis Gyogyszergyar Rt. Process for the preparation of crystalline polymorph of a platelet aggregation inhibitor drug
ATE557028T1 (de) 2003-08-04 2012-05-15 Wockhardt Ltd Neues verfahren zur herstellung von (+)-(s)- clopidogrelbisulfat form-i
DE10337773A1 (de) * 2003-08-13 2005-03-24 Krka Tovarna Zdravil, D.D. Kristallisation von festen Formen von Clopidogrel-Additionssalzen
EP1772455A3 (en) * 2004-03-05 2007-06-27 IPCA Laboratories Limited Industrial process for preparation a polmorph of clopidogrel hydrogen sulphate

Also Published As

Publication number Publication date
SI1740593T1 (sl) 2016-08-31
EA200601822A1 (ru) 2007-02-27
EP1740593B1 (en) 2016-04-06
US7999106B2 (en) 2011-08-16
PL1740593T3 (pl) 2016-09-30
ES2577303T3 (es) 2016-07-14
US20090234123A1 (en) 2009-09-17
WO2005100364A1 (en) 2005-10-27
HRP20160757T1 (hr) 2016-08-12
EA010198B1 (ru) 2008-06-30
EP1740593A1 (en) 2007-01-10
NO339878B1 (no) 2017-02-13
HUE029459T2 (en) 2017-02-28

Similar Documents

Publication Publication Date Title
NO20065321L (no) Fremgangsmate for fremstilling av clopidogrelhydrogensulfat polymorf for I
DE60230327D1 (de) Polymorphe von clopidogrel-hydrogensulfat
NO20075809L (no) DNA-PK inhibitorer
MX2008016423A (es) Arilamidas sustituidas con tetrazol.
MX2007003108A (es) Compuestos imidazo-3-il-amina sustituidos y biciclicos.
MX2009000480A (es) Bencilaminas, un proceso para su produccion y su uso como agentes antiinflamatorios.
WO2006099468A3 (en) Process for the purification of duloxetine hydrochloride
IL183700A0 (en) Process for production of (4,5-dihydroisoxazol-3-yl)thio-carboxamidine salts
UA93531C2 (en) Novel hydrogen sulfate salt
IL183591A0 (en) Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
TN2010000219A1 (en) 5-[(3,3,3-trifluoro-2-hydroxy-1-arylpropyl)amino]-1h-quinolin-2-ones, a process for their production and their use as anti-inflammatory agents
NO20084301L (no) Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler
MY144180A (en) Method for producing strontium ranelate and its hydrates
TW200745137A (en) Thieno[2,3-b]pyridine-5-carbonitriles as protein kinase inhibitors
PL1656381T3 (pl) Krystalizacja stałych postaci soli addycyjnych klopidogrelu
IL200323A0 (en) Synthesis of glyt-1 inhibitors
NO20064884L (no) Kjemisk fremgangsmate og ny krystallinsk form
DK1501838T3 (da) Fremgangsmåde til fremstilling af clopidogrel
GB0402262D0 (en) Process for the manufacture of organic compounds
EA200700550A1 (ru) Производные алкилидентетрагидронафталина, способ их получения и их применение в качестве противовоспалительных средств
WO2008004249A3 (en) An improved process for the preparation of clopidogrel and its pharmaceutically acceptable salts
SG153856A1 (en) Chemical process
WO2006010620A3 (en) Olanzapine salts and their conversion to olanzapine free base
TW200716555A (en) Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents
NO20065157L (no) Biotransformasjon av colchicinoidforbindelser

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees